Immediate Release: 25th June 2004
SOPHEON PLC
('Sopheon')
AGM Statement
Sopheon plc is pleased to announce that all resolutions proposed at today's
Annual General Meeting were duly passed.
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 883 000
Arif Karimjee, CFO
Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100
Andrew Tan + 44 (0) 7957 203 685
Barbara Jansen Citigate First Financial Tel : + 31 (0) 205 754 010
About Sopheon
Sopheon (LSE:SPE) is an international provider of software tools, experts and
content that help organizations improve the business impact of product
development. Sopheon enables clients to achieve higher, faster return on
innovation and product development investments through technology and
human-based decision support. The company's products and services include its
flagship Accolade® product development system which incorporates knowledge
network (formerly Organik®) expertise-sharing technology, and the Monitor
software for compliance management. Sopheon is listed on the AIM market of the
London Stock Exchange and on the Euronext in the Netherlands. For more
information, please visit www.sopheon.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.